Stabilized Urinary Biogenic Amines Measured in Clinical Chemistry Laboratories
|
By LabMedica International staff writers Posted on 23 Feb 2021 |

Image: The Dionex CoulArray Coulometric Array Detector (Photo courtesy of Thermo Fisher Scientific).
Carcinoid tumors are rare neuroendocrine tumors deriving from enterochromaffin cells secreting serotonin. The measurement of urinary 5-hydroxyindoleacetic acid (5-HIAA), the main product of serotonin metabolism, is used for the diagnosis and follow-up for this tumor.
Neuroblastomas are neoplasms that arise from neural crest-derived cell precursors of postganglionic sympathetic neurons and are characterized by excessive production of catecholamines (CATs). 5-HIAA, vanillylmandelic (VMA), homovanillic acid (HVA), catecholamines and metanephrines are produced in excess by catecholamine-producing tumors.
Medical Biochemists at the Lausanne University Hospital (Lausanne, Switzerland) obtained 22 urine spots from enrollees (aged 25 to 65, 50% males) and were aliquoted in 250 µL polypropylene tubes. The pH of urines was immediately measured using pH indicator strips. Each of the 22 urine samples was split into three sub-samples, one of which was supplemented by 5 mL of 6 M HCl per liter of urine (“HCl urine”), the second by 10 grams citrate per liter of urine (“citrate urine”), and the third was unmodified (“native urine”).
All the analytical methods used throughout the study were the routine methods from the laboratory and were fully validated. 5-HIAA, VMA, and HVA were measured in one aliquot by LC-MS/MS using a dilute-and-shoot sample preparation. The CATs were quantified in the third aliquot using the RECIPE catecholamine kit (Munich, Germany) using a 5600A electrochemical CoulArray system coupled to an isocratic HPLC (ESA-Dionex, Sunnyvale, CA, USA). CATs were also quantified by LC-MS/MS.
The scientists reported that that catecholamines degradation was prevented by HCl and citrate and that 5-HIAA was degraded in five out of 22 samples collected with HCl. All biogenic amines were efficiently stabilized by citrate for four weeks at 22 °C, except epinephrine (48 hours at 4 °C, or four weeks at −20 °C). Sodium citrate did not cause quantification or analytical artifacts concerns.
The authors concluded that sodium citrate is a non-hazardous alternative to HCl for patients to send unfrozen urine samples to the laboratory which may safely store the sample for four weeks. The team proposes to replace HCl by sodium citrate for stabilizing urinary 5-HIAA, VMA, HVA, catecholamines and total metanephrines as a safe alternative for clinical chemistry laboratory and patients. The study was published in the March, 2021 issue of the journal Clinica Chimica Acta.
Related Links:
Lausanne University Hospital
RECIPE
ESA-Dionex
Neuroblastomas are neoplasms that arise from neural crest-derived cell precursors of postganglionic sympathetic neurons and are characterized by excessive production of catecholamines (CATs). 5-HIAA, vanillylmandelic (VMA), homovanillic acid (HVA), catecholamines and metanephrines are produced in excess by catecholamine-producing tumors.
Medical Biochemists at the Lausanne University Hospital (Lausanne, Switzerland) obtained 22 urine spots from enrollees (aged 25 to 65, 50% males) and were aliquoted in 250 µL polypropylene tubes. The pH of urines was immediately measured using pH indicator strips. Each of the 22 urine samples was split into three sub-samples, one of which was supplemented by 5 mL of 6 M HCl per liter of urine (“HCl urine”), the second by 10 grams citrate per liter of urine (“citrate urine”), and the third was unmodified (“native urine”).
All the analytical methods used throughout the study were the routine methods from the laboratory and were fully validated. 5-HIAA, VMA, and HVA were measured in one aliquot by LC-MS/MS using a dilute-and-shoot sample preparation. The CATs were quantified in the third aliquot using the RECIPE catecholamine kit (Munich, Germany) using a 5600A electrochemical CoulArray system coupled to an isocratic HPLC (ESA-Dionex, Sunnyvale, CA, USA). CATs were also quantified by LC-MS/MS.
The scientists reported that that catecholamines degradation was prevented by HCl and citrate and that 5-HIAA was degraded in five out of 22 samples collected with HCl. All biogenic amines were efficiently stabilized by citrate for four weeks at 22 °C, except epinephrine (48 hours at 4 °C, or four weeks at −20 °C). Sodium citrate did not cause quantification or analytical artifacts concerns.
The authors concluded that sodium citrate is a non-hazardous alternative to HCl for patients to send unfrozen urine samples to the laboratory which may safely store the sample for four weeks. The team proposes to replace HCl by sodium citrate for stabilizing urinary 5-HIAA, VMA, HVA, catecholamines and total metanephrines as a safe alternative for clinical chemistry laboratory and patients. The study was published in the March, 2021 issue of the journal Clinica Chimica Acta.
Related Links:
Lausanne University Hospital
RECIPE
ESA-Dionex
Latest Clinical Chem. News
- Compact Raman Imaging System Detects Subtle Tumor Signals
- Noninvasive Blood-Glucose Monitoring to Replace Finger Pricks for Diabetics
- POC Breath Diagnostic System to Detect Pneumonia-Causing Pathogens
- Online Tool Detects Drug Exposure Directly from Patient Samples
- Chemical Imaging Probe Could Track and Treat Prostate Cancer
- Mismatch Between Two Common Kidney Function Tests Indicates Serious Health Problems
- VOCs Show Promise for Early Multi-Cancer Detection
- Portable Raman Spectroscopy Offers Cost-Effective Kidney Disease Diagnosis at POC
- Gold Nanoparticles to Improve Accuracy of Ovarian Cancer Diagnosis
- Simultaneous Cell Isolation Technology Improves Cancer Diagnostic Accuracy
- Simple Non-Invasive Hair-Based Test Could Speed ALS Diagnosis
- Paper Strip Saliva Test Detects Elevated Uric Acid Levels Without Blood Draws
- Prostate Cancer Markers Based on Chemical Make-Up of Calcifications to Speed Up Detection
- Breath Test Could Help Detect Blood Cancers
- ML-Powered Gas Sensors to Detect Pathogens and AMR at POC
- Saliva-Based Cancer Detection Technology Eliminates Need for Complex Sample Preparation
Channels
Molecular Diagnostics
view channel
Blood Test Could Identify Biomarker Signature of Cerebral Malaria
Malaria remains a major cause of death and long-term disability in many low- and middle-income countries, with around 600,000 deaths reported globally each year. The most severe form, cerebral malaria,... Read more
World’s First Biomarker Blood Test to Assess MS Progression
Multiple sclerosis (MS) disease activity is caused by an abnormal immune response that results in damage to the brain and spinal cord. However, there is a lack of reliable tools to measure or predict MS progression.... Read moreHematology
view channel
MRD Tests Could Predict Survival in Leukemia Patients
Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk
Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more
Microvesicles Measurement Could Detect Vascular Injury in Sickle Cell Disease Patients
Assessing disease severity in sickle cell disease (SCD) remains challenging, especially when trying to predict hemolysis, vascular injury, and risk of complications such as vaso-occlusive crises.... Read more
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read moreImmunology
view channel
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read more
Blood Test Could Identify Colon Cancer Patients to Benefit from NSAIDs
Colon cancer remains a major cause of cancer-related illness, with many patients facing relapse even after surgery and chemotherapy. Up to 40% of people with stage III disease experience recurrence, highlighting... Read moreMicrobiology
view channel
New UTI Diagnosis Method Delivers Antibiotic Resistance Results 24 Hours Earlier
Urinary tract infections affect around 152 million people every year, making them one of the most common bacterial infections worldwide. In routine medical practice, diagnosis often relies on rapid urine... Read more
Breakthroughs in Microbial Analysis to Enhance Disease Prediction
Microorganisms shape human health, ecosystems, and the planet’s climate, yet identifying them and understanding how they are related remains a major scientific challenge. Even with modern DNA sequencing,... Read morePathology
view channel
Genetics and AI Improve Diagnosis of Aortic Stenosis
Aortic stenosis is a progressive narrowing of the aortic valve that restricts blood flow from the heart and can be fatal if left untreated. There are currently no medical therapies that can prevent or... Read more
AI Tool Simultaneously Identifies Genetic Mutations and Disease Type
Interpreting genetic test results remains a major challenge in modern medicine, particularly for rare and complex diseases. While existing tools can indicate whether a genetic mutation is harmful, they... Read more
Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups
Medicinal syrups contaminated with toxic chemicals have caused the deaths of hundreds of children worldwide, exposing a critical gap in how these products are tested before reaching patients.... Read more
Tumor Signals in Saliva and Blood Enable Non-Invasive Monitoring of Head and Neck Cancer
Head and neck cancers are among the most aggressive malignancies worldwide, with nearly 900,000 new cases diagnosed each year. Monitoring these cancers for recurrence or relapse typically relies on tissue... Read moreTechnology
view channel
AI Predicts Colorectal Cancer Survival Using Clinical and Molecular Features
Colorectal cancer is one of the most common and deadly cancers worldwide, and accurately predicting patient survival remains a major clinical challenge. Traditional prognostic tools often rely on either... Read more
Diagnostic Chip Monitors Chemotherapy Effectiveness for Brain Cancer
Glioblastoma is one of the most aggressive and fatal brain cancers, with most patients surviving less than two years after diagnosis. Treatment is particularly challenging because the tumor infiltrates... Read moreIndustry
view channel
BD and Penn Institute Collaborate to Advance Immunotherapy through Flow Cytometry
BD (Becton, Dickinson and Company, Franklin Lakes, NJ, USA) has entered into a strategic collaboration with the Institute for Immunology and Immune Health (I3H, Philadelphia, PA, USA) at the University... Read more







